Holen Sie sich die Stockscreener-App
1.30
46.40%
0.412
Finanzdaten der Prelude Therapeutics Inc-Aktie (PRLD)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
8.12%
34.34
|
37.38 | 33.38 | 32.40 | 29.11 |
| Operating Income/Loss |
8.12%
-34.34
|
-37.38 | -33.38 | -32.40 | -29.11 |
| Income/Loss From Continuing Operations Before Tax |
4.97%
-31.43
|
-33.08 | -30.61 | -30.43 | -27.72 |
| Income/Loss From Continuing Operations After Tax |
4.97%
-31.43
|
-33.08 | -30.61 | -30.43 | -27.72 |
|
Net Income/Loss
|
4.97%
-31.43
|
-33.08 | -30.61 | -30.43 | -27.72 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,360%
75.74
|
3.0783 | 67.64 | 56.24 | 47.74 |
| Diluted Average Shares |
2,360%
75.74
|
3.0783 | 67.64 | 56.24 | 47.74 |
| Basic Earnings Per Share |
10.64%
-0.42
|
-0.47 | -0.45 | -0.54 | -0.58 |
| Diluted Earnings Per Share |
10.64%
-0.42
|
-0.47 | -0.45 | -0.54 | -0.58 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):